We are live on ! Find out more
NPSP

NPS PHARMACEUTICALS INC
NPSP

Delisted

NPSP was delisted on the 20th of February, 2015.

213 hedge funds and large institutions have $3.63B invested in NPS PHARMACEUTICALS INC in 2014 Q4 according to their latest regulatory filings, with 45 funds opening new positions, 68 increasing their positions, 83 reducing their positions, and 28 closing their positions.

New
Increased
Maintained
Reduced
Closed

61% more first-time investments, than exits

New positions opened: 45 | Existing positions closed: 28

60% more call options, than puts

Call options by funds: $104M | Put options by funds: $64.9M

39% more capital invested

Capital invested by funds: $2.61B → $3.63B (+$1.02B)

7% more funds holding

Funds holding: 200213 (+13)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

18% less repeat investments, than reductions

Existing positions increased: 68 | Existing positions reduced: 83

Holders
213
Holders Change
+13
Holders Change %
+6.5%
% of All Funds
5.68%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.05%
New
45
Increased
68
Reduced
83
Closed
28
Calls
$104M
Puts
$64.9M
Net Calls
+$38.7M
Net Calls Change
+$41.2M
Name Holding Trade Value Shares
Change
Change in
Stake
AI
126
Axiom Investors
Connecticut
$1.07M +$896K +30,030 New
WMSA
127
Weiss Multi-Strategy Advisers
New York
$1.07M -$149K -5,000 -14%
EEG
128
E.E. Geduld
$1.07M +$149K +5,000 +20%
PCM
129
Prelude Capital Management
New York
$1.07M +$894K +29,956 New
SKK
130
Shepherd Kaplan Krochuk
Massachusetts
$1.04M
Public Employees Retirement Association of Colorado
131
Public Employees Retirement Association of Colorado
Colorado
$1M
PAM
132
Paradigm Asset Management
New York
$984K -$32.8K -1,100 -4%
Mirae Asset Global Investments
133
Mirae Asset Global Investments
South Korea
$957K +$19.8K +662 +3%
Comerica Bank
134
Comerica Bank
Texas
$944K +$394K +13,201 +100%
N
135
Nuveen
North Carolina
$942K -$568K -19,018 -42%
AL
136
Airain Ltd
Guernsey
$892K +$343K +11,481 +85%
NPGCU
137
Napier Park Global Capital (US)
New York
$861K +$718K +24,065 New
US Bancorp
138
US Bancorp
Minnesota
$773K -$22.7K -761 -3%
LPL Financial
139
LPL Financial
California
$762K +$5.49K +184 +0.9%
MAM
140
Martingale Asset Management
Massachusetts
$715K -$4.51K -151 -0.8%
KPF
141
K2 Principal Fund
Ontario, Canada
$715K +$597K +20,000 New
SO
142
STRS Ohio
Ohio
$683K -$44.8K -1,500 -7%
Principal Financial Group
143
Principal Financial Group
Iowa
$659K -$156K -5,238 -22%
Legal & General Group
144
Legal & General Group
United Kingdom
$576K -$12.9K -431 -3%
Commonwealth Equity Services
145
Commonwealth Equity Services
Massachusetts
$554K +$462K +15,478 New
OPPM
146
Opus Point Partners Management
New York
$553K +$462K +15,471 New
GCP
147
GSA Capital Partners
United Kingdom
$540K -$953K -31,918 -68%
ACPU
148
Arrowgrass Capital Partners (US)
Delaware
$537K -$9.7M -324,927 -96%
GH
149
GAM Holding
Switzerland
$537K
AP
150
AHL Partners
United Kingdom
$534K +$445K +14,915 New

NPSP Hedge Fund Activity: Q4 2014 in Review

213 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in NPS PHARMACEUTICALS INC (NPSP) for Q4 2014, worth a combined $3.63B — up 39% from $2.61B a quarter earlier.

Buyers outnumbered sellers: 45 funds opened new NPSP positions and 28 closed out — a net gain of 17 holders — while 68 added to existing stakes and 83 trimmed.

The largest buyer was First Trust Advisors, opening a new position worth an estimated $70.9M. The largest seller was Wells Fargo, cutting an estimated $29.9M.

  • 213 institutional investors held NPS PHARMACEUTICALS INC (NPSP) as of Q4 2014, up from 200 in Q3 2014.
  • Funds reported $3.63B of NPS PHARMACEUTICALS INC stock for Q4 2014, up 39% quarter-over-quarter.
  • 45 funds opened new NPS PHARMACEUTICALS INC positions in Q4 2014 and 28 closed out, a net change of +17 holders.
  • The largest NPS PHARMACEUTICALS INC buyer in Q4 2014 was First Trust Advisors, an estimated $70.9M added.
  • The largest NPS PHARMACEUTICALS INC seller in Q4 2014 was Wells Fargo, an estimated $29.9M sold.

Based on aggregated 13F filings for Q4 2014.